5-138873449-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015564.3(LRRTM2):c.1112C>T(p.Ala371Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015564.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRTM2 | NM_015564.3 | c.1112C>T | p.Ala371Val | missense_variant | Exon 2 of 2 | ENST00000274711.7 | NP_056379.1 | |
CTNNA1 | NM_001903.5 | c.1063-12763G>A | intron_variant | Intron 7 of 17 | ENST00000302763.12 | NP_001894.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRTM2 | ENST00000274711.7 | c.1112C>T | p.Ala371Val | missense_variant | Exon 2 of 2 | 1 | NM_015564.3 | ENSP00000274711.5 | ||
CTNNA1 | ENST00000302763.12 | c.1063-12763G>A | intron_variant | Intron 7 of 17 | 1 | NM_001903.5 | ENSP00000304669.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1112C>T (p.A371V) alteration is located in exon 2 (coding exon 2) of the LRRTM2 gene. This alteration results from a C to T substitution at nucleotide position 1112, causing the alanine (A) at amino acid position 371 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at